Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

RACE ONCOLOGY LTD

INVESTOR PRESENTATION - RACE ONCOLOGY LTD

ASX:RAC

RACE ONCOLOGY LTD

Health Care

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.

Market Cap

$237.09m

Price at Close

$1.85

4w avg. Volume

640.08k

4w avg. Turnover

$908.04k

Announcements
announcementt+2 movementdate
  • Breast Cancer Clinical Trial Program Initiated

    Progress Report

  • -

    25 Nov 2020

-

25 Nov 2020
  • Impressive Preclinical Bisantrene Breast Cancer Results

    Progress Report · Market sensitive

  • +15.63%

    23 Nov 2020

+15.63%

23 Nov 2020
  • Cleansing Notice

    Issued Capital

  • -2.10%

    16 Nov 2020

-2.10%

16 Nov 2020
  • Appendix 2A-Exercise of Options

    Issued Capital

  • -2.10%

    16 Nov 2020

-2.10%

16 Nov 2020
  • Bisantrene data published in European Journal of Haematology

    Progress Report

  • +9.84%

    10 Nov 2020

+9.84%

10 Nov 2020
  • Phase II Bisantrene trial data to be presented at ASH 2020

    Progress Report

  • +23.92%

    05 Nov 2020

+23.92%

05 Nov 2020
  • Quarterly Activity Report & Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • -5.39%

    29 Oct 2020

-5.39%

29 Oct 2020
  • Annual Report to Shareholders

    Periodic Reports

  • -1.99%

    28 Oct 2020

-1.99%

28 Oct 2020
  • Letter to Shareholders, Notice of AGM & Proxy Form

    Notice Of Meeting

  • -1.99%

    28 Oct 2020

-1.99%

28 Oct 2020
  • Appendix 3Z-Chris Ntoumenopoulos

    Shareholder Details

  • -1.99%

    28 Oct 2020

-1.99%

28 Oct 2020
Market Data

Current Price

$1.85

52WK HIGH

$2.05

52WK LOW

$0.14

1YR RETURN

+1133.33%

1YR RETURN VS. SECTOR

+1114.53%

90 DAY RETURN

+124.24%

ASX RANK

545

/2,024

SECTOR RANK

12

/47

SHARES OUTSTANDING

128.16m
ASX:RAC

RACE ONCOLOGY LTD

Health Care

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.

Market Cap

$237.09m

Price at Close

$1.85

4w avg. Volume

640.08k

4w avg. Turnover

$908.04k

ASX:RAC is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.